Cargando…

30. RADIOSURGERY FOLLOWED BY TUMOR TREATING FIELDS FOR BRAIN METASTASES (1–10) FROM NSCLC IN THE PHASE 3 METIS TRIAL

BACKGROUND: Tumor Treating Fields (TTFields) are non-invasive, loco-regional, anti-mitotic treatment modality comprising alternating electric fields. TTFields have demonstrated efficacy in preclinical non-small cell lung cancer (NSCLC) models. TTFields treatment to the brain was safe and extended ov...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mehta, Minesh P, Gondi, Vinai, Brown, Paul, Ahluwalia, Manmeet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Supplement Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401333/ http://dx.doi.org/10.1093/noajnl/vdaa073.018

Ejemplares similares

TRLS-01. RADIOSURGERY FOLLOWED BY TUMOR TREATING FIELDS (TTFIELDS) FOR BRAIN METASTASES (1–10) FROM NSCLC IN THE PHASE 3 METIS TRIAL
por: Mehta, Minesh, et al.
Publicado: (2019)

CLRM-10 METIS (EF-25): A PIVOTAL, RANDOMIZED CONTROLLED STUDY OF TUMOR TREATING FIELDS IN PATIENTS WITH 1–10 BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER
por: Mehta, Minesh, et al.
Publicado: (2022)

Integration of Systemic Therapy and Stereotactic Radiosurgery for Brain Metastases
por: Tonse, Raees, et al.
Publicado: (2021)

Recent advances in managing brain metastasis
por: Kotecha, Rupesh, et al.
Publicado: (2018)

Advances in radiotherapy for brain metastases
por: Gondi, Vinai, et al.
Publicado: (2021)

The Evolving Role of Tumor Treating Fields in Managing Glioblastoma: Guide for Oncologists
por: Burri, Stuart H., et al.
Publicado: (2018)

MMAP-10 ADVERSE RADIATION EFFECT AFTER STEREOTACTIC RADIOSURGERY AND IMMUNOTHERAPY/TARGETED THERAPY FOR MELANOMA BRAIN METASTASES
por: Phuong, Christina, et al.
Publicado: (2022)

Zero Setup Margin Mask versus Frame Immobilization during Gamma Knife(®) Icon™ Stereotactic Radiosurgery for Brain Metastases
por: Kutuk, Tugce, et al.
Publicado: (2022)

An Excellent Clinical Outcome with Stereotactic Radiosurgery in a Geriatric Patient with Multiple and Recurrent Brain Metastases
por: Thapa, Bicky, et al.
Publicado: (2017)

OTHR-07. Systematic Review and Meta-analysis of Lung Cancer Brain Metastasis and Primary Tumor PD-L1 Expression Discordance
por: Tonse, Raees, et al.
Publicado: (2021)

RADI-01. Cystic brain metastases managed with reservoir placement and stereotactic radiosurgery
por: Park, David, et al.
Publicado: (2021)

Phase II multicenter trial combining nivolumab and radiosurgery for NSCLC and RCC brain metastases
por: Wong, Philip, et al.
Publicado: (2023)

45. DELAY OR FAILURE TO ADMINISTER STEREOTACTIC RADIOSURGERY TO THE CAVITY AFTER SURGERY FOR BRAIN METASTASES. AN INTENTION-TO-TREAT ANALYSIS
por: O’Brien, Diana Roth, et al.
Publicado: (2020)

43. DELAYS IN ADJUVANT STEREOTACTIC RADIOSURGERY REDUCE LOCAL CONTROL FOR RESECTED BRAIN METASTASES
por: Roth O’Brien, Diana, et al.
Publicado: (2020)

RADI-25. REPEAT STEREOTACTIC RADIOSURGERY FOR RECURRENT BRAIN METASTASES
por: Krivosheya, Daria, et al.
Publicado: (2019)

NEIM-02 CHARACTERIZATION OF LARGE BRAIN METASTASES WITH(18)F-FLUCICLOVINE PET/CT TREATED WITH STAGED STEREOTACTIC RADIOSURGERY (SSRS): INTERIM ANALYSIS OF A PILOT STUDY
por: Rosa, Alonso La, et al.
Publicado: (2023)

Stereotactic Radiosurgery for Glioblastoma
por: Redmond, Kristin J, et al.
Publicado: (2015)

RADI-11. Evaluating the Tissue Effects of Dose-escalated Pre-operative Stereotactic Radiotherapy for Resectable Brain Metastasis
por: Kotecha, Rupesh, et al.
Publicado: (2021)

31. RADIATION NECROSIS IN STEREOTACTIC RADIOSURGERY AND CHECKPOINTS INHIBITORS FOR BRAIN METASTASES FROM LUNG ADENOCARCINOMA
por: Jurica, James, et al.
Publicado: (2020)

RADI-07. Individualized Nomogram for Predicting Survival of Patients with Brain Metastases after Stereotactic Radiosurgery
por: Wen, Lei, et al.
Publicado: (2021)

MLTI-03. The relevance of the count of brain metastases for treatment and outcome in NSCLC
por: Reinecke, David, et al.
Publicado: (2021)

The Influence of Biomarker Mutations and Systemic Treatment on Cerebral Metastases from NSCLC Treated with Radiosurgery
por: Lee, Min Ho, et al.
Publicado: (2017)

Comparison of Prognostic Indices in NSCLC Patients with Brain Metastases after Radiosurgery
por: Gao, Hong Xiang, et al.
Publicado: (2018)

Métis health in Canada: a scoping review of Métis-specific health literature
por: Gmitroski, Krysta-Leigh, et al.
Publicado: (2023)

59. A RADIOMICS-BASED MACHINE LEARNING MODEL FOR DISTINGUISHING RADIATION NECROSIS FROM PROGRESSION OF BRAIN METASTASES TREATED WITH STEREOTACTIC RADIOSURGERY (SRS)
por: Chen, Xuguang, et al.
Publicado: (2020)

MMAP-07 IMPACT OF SINGLE AND DUAL IMMUNE CHECKPOINT BLOCKADE ON RISK OF RADIATION NECROSIS AMONG PATIENTS WITH BRAIN METASTASES TREATED WITH STEREOTACTIC RADIOSURGERY
por: Vaios, Eugene, et al.
Publicado: (2022)

Radiotherapy and radiosurgery for meningiomas
por: Chen, William C, et al.
Publicado: (2023)

MMAP-11 VOLUMETRIC STUDY OF BRAIN METASTASES IN EGFR-POSITIVE NSCLC TREATED WITH OSIMERTINIB WITH OR WITHOUT CNS-DIRECTED RADIATION THERAPY
por: Ni, Lisa, et al.
Publicado: (2022)

TRLS-05. EARLY RESULTS FROM A PROSPECTIVE PHASE I/II DOSE ESCALATION STUDY OF NEOADJUVANT RADIOSURGERY FOR BRAIN METASTASES
por: Murphy, Erin, et al.
Publicado: (2019)

MLTI-06. Surgical resection plus stereotactic radiosurgery versus SRS alone for large brain metastases: a comparative study
por: Gutierrez, Enrique, et al.
Publicado: (2021)

RADI-22. Toxicity and local control outcomes for brain metastases managed with resection and aggressive reirradiation after initial radiosurgery failure
por: Bhatia, Rohini, et al.
Publicado: (2021)

BIMG-19. (18)F-FLUCICLOVINE PET/CT TO DISTINGUISH RADIATION NECROSIS FROM TUMOR PROGRESSION IN BRAIN METASTASES TREATED WITH STEREOTACTIC RADIOSURGERY: A PROSPECTIVE PILOT STUDY
por: Tom, Martin
Publicado: (2021)

Brain metastasis and treatment
por: Ahluwalia, Manmeet S., et al.
Publicado: (2014)

RADI-23. Exploring the optimal timing of routine initial surveillance MRI following treatment of brain metastases with stereotactic radiosurgery: a comparison of two approaches
por: Lin, Timothy, et al.
Publicado: (2021)

Complete manual of therapy with the meti-steroids
Publicado: (1956)

BSCI-09. Multiomic single cell analysis reveals emerging principles of tumor immune microenvironment inherent to NSCLC brain metastases
por: Wen, Lei, et al.
Publicado: (2021)

OTEH-2. High-dimensional analysis of spatial immune cell heterogeneity in glioblastoma reveals differences between contrast-enhancing and non-contrast-enhancing tumor rims
por: Watson, Dionysios C, et al.
Publicado: (2021)

CLRM-12 TITLE: STEREOTACTIC RADIOSURGERY (ADJUVANT OR NEOADJUVANT) COMPARED TO HIPPOCAMPAL AVOIDANCE WHOLE BRAIN RADIATION THERAPY WITH SIMULTANEOUS INTEGRATED BOOST FOR LIMITED BRAIN METASTASES (SRS-CHART): PHASE III OPEN-LABEL PARALLEL-GROUP RANDOMIZED CONTROLLED TRIAL
por: Dasgupta, Archya, et al.
Publicado: (2022)

Medical management of brain metastases
por: Lauko, Adam, et al.
Publicado: (2020)

State-of-the-art considerations in small cell lung cancer brain metastases
por: Lukas, Rimas V., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pev25rsfk3n1a9da57ham53jpf